PersonFounderScientist
Dennis X. Hu
Dennis X. Hu is the founder and CEO of Drug Hunter, a subscription knowledge platform that distills the science behind new medicines for more than 200 R&D institutions, including most of the world's top pharma and biotech companies. A medicinal chemist by training, he led small-molecule teams at Genentech and the biotech RAPT Therapeutics (where he helped invent the Phase II oncology candidate tivumecirnon) before turning a side project into a fully remote company of 20+ employees that reaches millions of searches a year and runs entirely on subscription revenue.
drug hunterdrug discoverymedicinal chemistryfounderceochemical biology